A new technology to improve the lives of diabetic people may be soon coming in the market. Researchers have come up with an implantable artificial pancreas, which can monitor glucose levels and deliver insulin as and when needed.
It had success in the laboratory and animal testing will soon begin in hopes of further advancement.
This technology has been a long time goal in hopes of simplifying the lives of Type 1 diabetes patients, who have to monitor, calculate and inject insulin into their bodies with either a needle or an insulin pump.
The issue with these traditional methods of providing the body with insulin are that there is a lag between when the dose is needed and when the effects of the dose starts taking place in a diabetics body.
Researchers have been working on this problem and they designed an algorithm that monitors glucose levels constantly, calculated the insulin dose required and delivers it immediately
Researchers said in a press conference that the algorithm is designed to work with implanted devices, specifically an artificial pancreas.
Ipads were connected to an insulin pump and were used to test the algorithm, the most recent study being the design of a chip that will be installed in devices to automate them.
The algorithm simulated the rise and fall of glucose levels in the body that would go through normal parts of the day, e.g. meals and sleep. Through computer simulations, researchers found that 80% of the time, blood glucose target ranges was met.
Frank Doyle, chair of the University of California-Santa Barbara chemical engineering department, said in a press release “The closed-circuit system provides much tighter control at an unprecedented level to minimize complications and to improve the quality of life.”
When the algorithms were first revealed. “It will have immediate benefits, as it will lower health-care costs in the country and it will reduce the amount of decisions people with diabetes need to make on a constant basis.”